Regencell Bioscience Lim... (RGC)

NASDAQ: RGC · Real-Time Price · USD

73.42

13.42 (22.37%)

At close: May 01, 2025, 3:59 PM

Regencell Bioscience Cash Flow Statement

Financials in USD. Fiscal year is July - June.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020	Jun 30, 2019	Dec 31, 2017	Dec 31, 2016	Dec 31, 2015
Net Income	-4.36M	-6.06M	-7.59M	-1.35M	-812.37K	-390.99K	112.3M	170.4M	153.4M
Depreciation & Amortization	745.59K	769.69K	604.4K	26.46K	9.52K	n/a	254.8M	230.7M	216.8M
Stock-Based Compensation	449.31K	922.62K	2.76M	n/a	n/a	n/a	n/a	n/a	n/a
Other Working Capital	-585.37K	-508.94K	-1.02M	552.98K	76.28K	n/a	-37.8M	-23.6M	-3.9M
Other Non-Cash Items	-248K	-85.4K	-10.73K	52.91K	19.03K	n/a	68M	65.6M	31.3M
Deferred Income Tax	n/a	1.42K	n/a	n/a	n/a	n/a	600K	2.4M	-10.9M
Change in Working Capital	-585.37K	-508.94K	-1.02M	552.98K	76.28K	n/a	-35M	-67.4M	35.5M
Operating Cash Flow	-4M	-4.96M	-5.27M	-767.31K	-726.57K	-390.99K	409.9M	410.5M	434.4M
Capital Expenditures	-5.38K	-27.39K	-780.88K	n/a	-117.84K	n/a	-250.4M	-214.9M	-185.7M
Cash Acquisitions	n/a	970.00	n/a	n/a	n/a	n/a	-171.6M	n/a	n/a
Purchase of Investments	-5M	-10M	-10M	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	10.25M	10.09M	n/a	n/a	n/a	n/a	n/a	3.6M	n/a
Other Investing Acitivies	n/a	86.37	-10K	n/a	n/a	n/a	11.4M	-12.3M	2.4M
Investing Cash Flow	5.24M	58.98K	-10.78M	n/a	-117.84K	n/a	-410.6M	-223.6M	-183.3M
Debt Repayment	n/a	n/a	n/a	612.06K	988.08K	480.99K	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a	-228.8M	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	102.28K	134.91K	-267.97K	-172.31K	n/a	n/a	-17M	-160M	-178.6M
Financial Cash Flow	102.28K	134.91K	22.41M	439.75K	988.08K	480.99K	-17M	-160M	-178.6M
Net Cash Flow	1.4M	-4.85M	6.36M	-327.57K	143.67K	90K	-17.7M	26.9M	72.5M
Free Cash Flow	-4.01M	-4.99M	-6.05M	-767.31K	-844.41K	-390.99K	159.5M	195.6M	248.7M